<![CDATA[Will The FDA Approve Iberdomide in Relapsed/Refractory Multiple Myeloma?]]>
The approval of iberdomide might expand the “tool belt” of novel drugs and combination approaches that may help advance towards a cure in multiple myeloma, according to Sagar Lonial, MD, FACP, FASCO. In February 2026, the FDA accepted a new drug …